- Home
- GAMB vs ZURA Comparison
GAMB vs ZURA Comparison
Compare GAMB & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAMB
- ZURA
- Stock Information
- Founded
- GAMB 2006
- ZURA 2022
- Country
- GAMB Jersey
- ZURA United States
- Employees
- GAMB N/A
- ZURA N/A
- Industry
- GAMB Services-Misc. Amusement & Recreation
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GAMB Consumer Discretionary
- ZURA Health Care
- Exchange
- GAMB Nasdaq
- ZURA Nasdaq
- Market Cap
- GAMB 338.0M
- ZURA 292.1M
- IPO Year
- GAMB 2021
- ZURA N/A
- Fundamental
- Price
- GAMB $11.77
- ZURA $3.16
- Analyst Decision
- GAMB Strong Buy
- ZURA Buy
- Analyst Count
- GAMB 4
- ZURA 6
- Target Price
- GAMB $14.75
- ZURA $15.80
- AVG Volume (30 Days)
- GAMB 225.6K
- ZURA 342.4K
- Earning Date
- GAMB 11-14-2024
- ZURA 11-07-2024
- Dividend Yield
- GAMB N/A
- ZURA N/A
- EPS Growth
- GAMB 306.73
- ZURA N/A
- EPS
- GAMB 0.78
- ZURA N/A
- Revenue
- GAMB $124,404,000.00
- ZURA N/A
- Revenue This Year
- GAMB $17.13
- ZURA N/A
- Revenue Next Year
- GAMB $11.30
- ZURA N/A
- P/E Ratio
- GAMB $15.17
- ZURA N/A
- Revenue Growth
- GAMB 27.63
- ZURA N/A
- 52 Week Low
- GAMB $7.52
- ZURA $2.00
- 52 Week High
- GAMB $13.00
- ZURA $6.35
- Technical
- Relative Strength Index (RSI)
- GAMB 70.74
- ZURA 29.68
- Support Level
- GAMB $10.20
- ZURA $4.00
- Resistance Level
- GAMB $13.00
- ZURA $4.85
- Average True Range (ATR)
- GAMB 0.45
- ZURA 0.35
- MACD
- GAMB 0.25
- ZURA -0.14
- Stochastic Oscillator
- GAMB 67.46
- ZURA 0.59
About GAMB Gambling.com Group Limited
Gambling.com Group Ltd is a multi-award-winning performance marketing company and a provider of digital marketing services in the online gambling industry. Its principal focus is on online casino and online sports betting and the fantasy sports industry. It generates revenue by referring online gamblers to online gambling operators.
About ZURA Zura Bio Limited
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.